Rosiglitazone plus gliclazide improves glycaemia in Type 2 diabetics compared to doubling the gliclazide dose

被引：0
|
作者：
James, RE
Wright, S
Zhou, B
Mather, RA
Jones, NP
机构：
[1] SmithKline Beecham, Harlow, Essex, England
[2] SmithKline Beecham, Collegeville, PA USA
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
895
引用
下载
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [21] Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide
    Belcher, G
    Lambert, C
    Goh, KL
    Edwards, G
    Valbuena, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (09) : 833 - 837
  • [22] Effectiveness and Safety of the Combination of Gliclazide with Metformin in Patients with Diabetes Type 2
    Tchaava, K.
    Gegeshidze, N.
    Shavdia, M.
    Ninashvili, N.
    Shervashidze, T.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S4 - S4
  • [23] Long-term combination therapy with pioglitazone plus metformin for type 2 diabetes: A randomised, comparative study with gliclazide plus metformin
    Edwards, G
    Lee, C
    Urquhart, R
    Herz, M
    Tan, M
    DIABETES, 2003, 52 : A118 - A118
  • [24] Efficacy and safety of pioglitazone in comparison to gliclazide in patients with type 2 diabetes
    Perriello, G
    Pampanelli, S
    Di Pietro, C
    Brunetti, P
    DIABETES, 2004, 53 : A484 - A484
  • [25] Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes
    Belcher, G
    Lambert, C
    Edwards, G
    Urquhart, R
    Matthews, DR
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 70 (01) : 53 - 62
  • [26] Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes
    Davis, TME
    Daly, F
    Walsh, JP
    Ilett, KF
    Beilby, JP
    Dusci, LJ
    Barrett, PHR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (03) : 223 - 230
  • [27] Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes
    van Bommel, Erik J. M.
    Smits, Mark M.
    Ruiter, Danique
    Muskiet, Marcel H. A.
    Kramer, Mark H. H.
    Nieuwdorp, Max
    Touw, Daan J.
    Heerspink, Hiddo J. L.
    Joles, Jaap A.
    van Raalte, Daniel H.
    JOURNAL OF HYPERTENSION, 2020, 38 (09) : 1811 - 1819
  • [28] Association of gliclazide and left ventricular mass in type 2 diabetic patients
    Pan, Nan-Hung
    Lee, Tsung-Ming
    Lin, Mei-Shu
    Huang, Chen-Ling
    Chang, Nen-Chung
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 (02) : 121 - 128
  • [29] Determination of gliclazide minimum concentration in type 2 diabetes mellitus patients
    Czyrski, Andrzej
    Resztak, Matylda
    Hermann, Tadeusz
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 1267 - 1270
  • [30] Effect of Dapagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, on Vascular Function in Patients with Type 2 Diabetes Compared with Gliclazide
    Lim, Soo
    Cherney, David
    DIABETES, 2019, 68
12345